Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China

scientific article

Safety of measles-containing vaccines in post-marketing surveillance in Anhui, China is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PONE.0172108
P932PMC publication ID5305249
P698PubMed publication ID28192490

P50authorDong Qing YeQ85642552
Hai-Feng PanQ37830269
P2093author name stringYong Sun
Fan-Ya Meng
Chang-Hao Wu
Bin-Bing Wang
Ji-Hai Tang
Yong-Gang Shen
P2860cites workDiarrhea: case definition and guidelines for collection, analysis, and presentation of immunization safety dataQ33763060
Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance dataQ34245754
Endemic and imported measles virus-associated outbreaks among adults, Beijing, China, 2013.Q35130285
The epidemiology of measles in Tianjin, China, 2005-2014.Q36278835
The epidemiological characteristics of measles and difficulties of measles elimination in Hang Zhou, ChinaQ37514780
Immunogenicity and safety of a measles-mumps-rubella-varicella vaccine following a 4-week or a 12-month interval between two doses.Q37850534
Effect of age on the risk of Fever and seizures following immunization with measles-containing vaccines in childrenQ40231546
Measles-containing vaccines and febrile seizures in children age 4 to 6 yearsQ40291310
Measles - United States, January 4-April 2, 2015.Q41064963
Accelerating measles elimination and strengthening routine immunization services in Guizhou Province, China, 2003-2009.Q41227726
Measles virusQ41612319
Febrile seizures following measles and varicella vaccines in young children in Australia.Q41637575
Measles mortality reduction contributes substantially to reduction of all cause mortality among children less than five years of age, 1990-2008.Q44651226
Safety of influenza A (H1N1) vaccine in postmarketing surveillance in ChinaQ30399259
Monitoring progress towards the elimination of measles in China: an analysis of measles surveillance dataQ30823469
Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentationQ30890095
Generalized convulsive seizure as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentationQ30890102
Fatigue: case definition and guidelines for collection, analysis, and presentation of immunization safety dataQ31107779
Rash including mucosal involvement: case definition and guidelines for collection, analysis, and presentation of immunization safety dataQ31107914
Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety dataQ31109981
Thrombocytopenia: case definition and guidelines for collection, analysis, and presentation of immunization safety dataQ31112245
Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety dataQ31115845
A 60-year review on the changing epidemiology of measles in capital Beijing, China, 1951-2011.Q31142094
A local reaction at or near injection site: case definition and guidelines for collection, analysis, and presentation of immunization safety dataQ33379317
Safety of measles-containing vaccines in 1-year-old childrenQ33419617
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectmeaslesQ79793
P304page(s)e0172108
P577publication date2017-02-13
P1433published inPLOS OneQ564954
P1476titleSafety of measles-containing vaccines in post-marketing surveillance in Anhui, China
P478volume12

Search more.